Your search for ‘PSA’ returned 1,114 results

The English Court of Appeal has suggested that the "Problem and Solution" (PSA) approach, much used by the EPO when considering obviousness, should be considered to be an "administrative tool" only which does not necessarily lead to the "correct" answer.

The Financial Services and Markets Bill ("FSM Bill") was read for the second time on 4 April 2022 and subsequently passed by the Singapore Parliament on 5 April 2022.

Senior housing transactions sit at the intersection of real estate, healthcare regulation, and resident care, making them fundamentally different from other commercial real estate transactions.

This article serves as a timely reminder on how these relatively new laws affect how patent specifications are drafted.

The seesawing judgments that led to this final outcome in Sandoz's favour and discuss the implications for both patentees and generics.

Today's guest post is by Corinne Fierro, Mildred Segura, and Farah Tabibkhoei, all of Reed Smith. These three are all part of the firm's left-coast, techno side of the product liability practice...

On October 20, 2011, the Federal Trade Commission and Department of Justice issued a final policy statement on accountable care organizations (ACOs) participating in the Medicare Shared Savings Program (MSSP).

During the Covid-19 pandemic, we witnessed a rapid shift in the way legal and business community interpret Force Majeure clauses in commercial contracts.

Patent disputes in India often involve multiple proceedings in different jurisdictions.

This newsletter summarizes the key points discussed in the judgment that could impact contracts between an Indian and a non-resident party.

Rule 3(5) of the Draft Rules prescribes that within 72 hours of receiving a <em>lawful order</em>

India's ever-expanding digital infrastructure in the wake of the pandemic has escalated the demand for new, updated, and improved regulatory mandates for strengthening cybersecurity and preventing cybercrime.

Tornado season is again upon us, bringing with it the threat of catastrophic property damage, upended lives, and interrupted businesses—as many multifamily developers and investors know all too well.

On July 5, 2016, the First Department of the Appellate Division of the Supreme Court of the State of New York affirmed the partial grant of Bank of New York Mellon's ("BNY") motion to dismiss certain claims...

On December 18, Judge William Pauley III of the U.S. District Court for the Southern District of New York denied Bank of New York Mellon's motion to dismiss RMBS claims...

On June 15, 2025, Celltrion announced that the FDA has approved a new 45mg/0.5mL single-dose vial presentation of STEQEYMA (ustekinumab-stba) for subcutaneous injection.

Survival periods for representations and warranties are frequently used in commercial agreements. The interplay between these survival periods and the Limitations Act...